Kanoria Chemicals Q2 FY26 results: revenue up, APAG demerger brings one-time gain

Pat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

KANORICHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹79.50

prior close

₹81.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+0.1% vs market

On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-0.6

15m

-0.6

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-0.2-0.3+0.1

Next day

-2.9+0.7-3.6

-3.8+0.6-4.3

-3.1+0.5-3.6

-3.8+1.1-4.9

-4.3+0.3-4.5

-4.4-0.2-4.2

15d

-5.8-2.2-3.6

-10.1-4.9-5.1

-8.2-7.5-0.7

-4.7-4.8+0.0

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kanoria Chemicals reported standalone revenue of Rs 19,087 lakhs in Q2 FY26, up 18.6% YoY. H1 FY26 PAT grew 54% to Rs 183 lakhs. EBITDA margin expanded to 10.8% from 7.5% in H1 FY25. Exceptional item of Rs 1,064 lakhs was impairment of APAG Holding AG investment. Consolidated PAT jumped to Rs 7,803 lakhs from a loss, boosted by a Rs 9,766 lakhs gain on loss of control of APAG, which ceased to be a subsidiary from July 31, 2025. Auditor issued an unmodified limited review report.

Likely market impact

Core chemicals business showing improvement with margin expansion and revenue growth. One-time gain from APAG demerger boosts consolidated earnings.